Workflow
宝莫股份: 关于股票交易异常波动公告

Group 1 - The stock of Shandong Baomo Biological Chemical Co., Ltd. (referred to as "the company") experienced abnormal trading fluctuations over three consecutive trading days on June 19 and June 20, 2025, as per the relevant regulations [1] - The company conducted a verification process regarding the abnormal trading fluctuations and confirmed that there were no undisclosed significant information or major changes affecting the stock price [1] - The board of directors confirmed that there are no matters that should have been disclosed according to the Shenzhen Stock Exchange listing rules that have not been disclosed, nor any significant information that could impact the trading price of the company's stock and its derivatives [1]